Accel Wealth Management Anixa Biosciences Inc Transaction History

Accel Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$2.55 - $4.1 $3,187 - $5,125	-1,250 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$2.88 - $5.5 $3,600 - $6,875	1,250 New	1,250 $4,000
Q3 2021 Nov 04, 2021	SELL	$3.57 - $5.6 $4,462 - $7,000	-1,250 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$3.27 - $7.14 $4,087 - $8,925	1,250 New	1,250 $6,000

5.5M

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $96.6M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Accel Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Accel Wealth Management with notifications on news.